Trim MDLZ 25-33% via tranched execution; revise stop to $65.00; maintain dividend on residual as defensive carry
Underweight is the correct directional call based on four-quarter sequential EPS contraction (30% decline: $0.57→$0.51→$0.44→$0.40), zero Q1'26 buybacks versus $1.52B in Q1'25, and Net Debt/EBITDA expansion to ~3.8x funding the $1.6B gap between capital returns and FCF. The 18.6x forward P/E embeds 23% EPS snapback that has not materialized; MDLZ hedges 6-12 months forward so cocoa normalization is back-end-loaded to late 2026/2027. Full Sell is not warranted given the structural floor: price +6.5% above rising 200 SMA at $58.28, $5B annual capital return program, 0.40 beta, and irreplaceable brand portfolio (Oreo/Cadbury/Toblerone/Milka/Clif). Dividend defense is sound on ~$5B operating cash flow basis with 3.33% yield providing defensive carry. GLP-1 secular threat to snack TAM remains the key structural risk warranting monitoring.
| Position | Action |
|---|---|
| Current levels ($62.50-$63.00) | Execute ~50% of trim (~12.5-16.5% of total target weight) |
| $63.50-$64.70 resistance zone retest | Execute remaining ~50% of trim reserved for this zone |
| Pre-Q3 earnings (late October) | Complete ~30-40% of total trim before binary catalyst |
| Hard exit trigger: 200 SMA break at $58.28 | Exit residual position entirely |
MDLZ is a mispriced defensive compounder with sub-1.0 PEG, 23% forward EPS growth, 3.33% dividend yield, upgraded FY26 guidance, and three concrete catalysts (Grenade US, Chiefs partnership, biscuits momentum) in a macro environment that favors low-beta staples.
| Indicator | Value | Signal |
|---|---|---|
| Price (Last Close) | $62.45 | neutral |
| 10 EMA | $62.61 | bearish |
| 50 SMA | $61.49 | bullish |
| 200 SMA | $58.38 | bullish |
| RSI (14) | 49.99 | neutral |
| MACD | 0.18 vs Signal 0.43, Histogram -$0.25 | bearish |
| Bollinger Upper | $64.75 | neutral |
| Bollinger Middle | $62.86 | neutral |
| Bollinger Lower | $60.97 | neutral |
| ATR (14) | $1.34 | neutral |
Support: 60.97 · 61.5 · 58.38 | Resistance: 62.86 · 64.7 · 64.75
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Retest of $63.50-$64.70 resistance zone
Then: Execute remaining ~50% of trim
↩ rebuts: “Bear's overvaluation concern”
EV: +$66+ on confirmed technical breakout above $64.75 (from current ~$64.70) · concedes: Healthy, normal consolidation within an intact uptrend; Post-earnings pullback of 3.1%; 6-month sector lag in Fed-pause environment where defensives naturally underperform momentum
MDLZ is a mature, leveraged, structurally-threatened consumer staples name trading at 22.5x trailing P/E with declining EPS for four consecutive quarters, a dividend not covered by TTM free cash flow, and secular category headwinds from GLP-1 drugs and regulatory pressures.
EV: $58 (200 SMA target) · concedes: Q2-25 operating margin spike to 32.7% shows pricing power exists at peak; Upgraded organic revenue outlook suggests top-line momentum; 7% recession odds and soft landing environment may support defensive positioning; Sponsorship deals and Grenade US launch provide marginal growth options
→ vs conservative: Beta of 0.4 and 3.33% dividend yield are defensive characteristics being paid for at premium prices, but the dividend is being funded at a FCF deficit — not a defensive holding but a yield trap
→ vs conservative: Negative dividend coverage makes holding for yield counterproductive — when did you last hold a defensive name where the dividend coverage was negative?
→ vs neutral: MACD crossed bearish, histogram at negative $0.25, RSI rolling over at midline, price capped beneath 50-day — yet neutral thesis recommends waiting for even lower entry, which is catching a falling knife
→ vs neutral: Bollinger band compression and ATR contraction don't guarantee bullish expansion — with four straight EPS declines and no Fed cuts priced for 2026, the spring is loading for downside
→ vs neutral: The 'attractive valuation' (PEG 0.91, P/E 18.3x) requires 23% EPS snapback after four declining quarters — if Q3 prints anywhere near current trajectory, forward multiple gets crushed
→ vs neutral: Failed breakout at $64.70 and rejection from Bollinger upper band confirms broken bull flag, not coiled bull
MDLZ trades at $62.45 (2026-09-02 close) in a post-rally consolidation after reaching $64.70 high on 2026-08-24. The stock sits 7.0% above the 200 SMA ($58.38) and 1.6% above the 50 SMA ($61.49), maintaining a bullish long-term structure. Short-term momentum has shifted bearish with MACD line crossing below signal (histogram -$0.25), 10 EMA declining from $63.57 peak, and RSI neutral at 49.99. Bollinger Bands show compression (upper $64.75, middle $62.86, lower $60.97) with ATR compressed to $1.34, indicating a coiled volatility setup primed for directional expansion. Key levels: immediate resistance at $62.86 (Bollinger middle/10 EMA cluster), with August high at $64.70-$64.75 as breakout trigger; support at $61.50-$61.78 (50 SMA zone) and $60.97 (Bollinger lower band). FINAL TRANSACTION PROPOSAL: HOLD — with positive bias for tactical adds on dips to $61.00-$61.50.
Market Capitalization
$78.43 billion
Beta
0.404
52-Week Range
$51.20 – $66.65
P/E (TTM)
22.51x
Forward P/E
18.28x
PEG Ratio
0.91
Price/Book
2.95x
EPS (TTM)
$2.73
Forward EPS
$3.36
Dividend Yield
3.33%
Book Value/Share
$20.80
TTM Revenue
$39.67 billion
Gross Margin (TTM)
31.1%
Operating Margin
22.0%
Net Profit Margin
8.9%
EBITDA (TTM)
$6.08 billion
Return on Equity (ROE)
13.3%
Return on Assets (ROA)
4.1%
Total Assets
$71,122 million
Total Liabilities
$45,318 million
Stockholders' Equity
$25,750 million
Total Debt
$21,622 million
Net Debt
$19,500 million
Net Debt/EBITDA
3.2x
Cash & Equivalents
$1,524 million
Goodwill & Intangibles
$43,759 million
Debt-to-Equity
82.6%
Current Ratio
0.599
Working Capital
-$10.76 billion
TTM Free Cash Flow
~$2.25 billion
Annualized Dividend
~$2.5 billion
FCF Yield
~2.9%
50-Day Moving Average
$61.53
200-Day Moving Average
$59.05
Strengths
Concerns
Mondelez International presents as a defensive, income-generating consumer staples holding with a $78.43B market cap and 3.33% dividend yield backed by $2.25B in TTM free cash flow, trading at a reasonable 18.3x forward P/E with a PEG ratio below 1.0. The company faces margin pressure with net margin at 8.9% and sequential EPS decline over four quarters, compounded by $21.6B in debt leverage and significant commodity/FX headwinds. The 0.4 beta and strong brand portfolio (Oreo, Cadbury, Milka) support its core holding appeal for income-focused portfolios, though near-term catalyst visibility remains limited given input cost volatility and emerging market exposure.
Macro: Fed is expected to deliver zero rate cuts in 2026 (89% probability on Polymarket, ~$7.9M traded), fully pricing a higher-for-longer stance that is neutral-to-supportive for cash-generative consumer staples like MDLZ. US recession odds are 7% (-1.5pp week), UK 8%, Japan 8% (-13.0pp), indicating a soft-landing consensus with sluggish real-income growth favoring value-priced, brand-elasticity-resistant staples. Peer divergence within staples: Coca-Cola separating from slower-moving rivals (winning bucket), while Kraft Heinz beat EPS but flagged weak North America volumes and Campbell's continues posting quarterly sales declines (losing bucket). MDLZ sits in the favored cohort with pricing power.